Key Metrics
Price Performance
30-DAY PRICE CHART
1-YEAR PERFORMANCE
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Novo Nordisk A/S is currently trading at $37.52, which is 53.9% below its 52-week high. With a beta of 0.27, the stock shows lower sensitivity to market movements.
Frequently Asked Questions
Is NVO a good buy right now?
Novo Nordisk A/S trades at 10.5x earnings. This is below market average, potentially undervalued. Current risk level is Medium based on 24.5% volatility.
Does NVO pay dividends?
Yes, Novo Nordisk A/S offers a dividend yield of 4.80%. This translates to approximately $1.80 per share annually.
How volatile is NVO?
With 30-day annualized volatility of 24.5% and beta of 0.27,NVO is classified as Medium risk. The stock tends to be more stable than the market average.
Related Assets
Track NVO Live
Add Novo Nordisk A/S to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALIMPORT BROKER FILE